The AHA expresses support for the Medicare Sequester COVID Moratorium Act (H.R. 315), legislation that would eliminate Medicare sequester cuts during the COVID-19 public health emergency.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
In a letter to the House Energy and Commerce Subcommittee on Oversight and Investigations AHA expressed a commitment to help end the COVID-19 pandemic and urged Congress to provide additional funds to the Provider Relief Fund and for vaccine distribution and administration,
AHA urges all health plans to help maximize health care capacity for the COVID-19 emergency by suspending utilization management processes that delay or prevent patients from being transferred or discharged to clinically appropriate settings and covering the cost of care at these sites.
The AHA today urged the Centers for Medicare & Medicaid Services to extend the deadline for hospitals to submit 2020 data for the Medicare Promoting Interoperability Program from March 1 to at least May 1, 2021, citing problems this year with the system used to submit the data.
AHA urges the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with a serious effort at drug pricing reform.
AHA Urges Biden to Provide Strong Federal Leadership on COVID-19 Vaccine Distribution and Administration
The Medicare Payment Advisory Commission (MedPAC, or the Commission) will vote this month on payment recommendations for 2022.
AHA comments on the Centers for Medicare & Medicaid Services’ proposed changes to the hospital and hospital health care complex cost report.
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.
AHA letter to HHS outlining leadership actions needed to expedite the administration of covid-19 vaccines.